A study to look at different doses and side effects of a new medicine - zinpentraxin alfa - in healthy people
A Phase Ia, Randomized, Investigator- and Subject-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single-Ascending Doses of RO7490677 in Healthy Volunteers
Autoimmune Disorder Crohn's Disease
For the latest version of this information please go to www.forpatients.roche.com